Increased expression of chemokine receptors CCR4 and CCR6 and decreased expression of the co-stimulatory molecules CD27 and CD28 were observed in CXCR3+ cells from patients with HR-MDS and AML (Supplementary Fig. S9A and S9B). This evidence concerns the gene CCR6 and acute myeloid leukemia.